Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/physique/drug-targeting-and-stimuli-sensitive-drug-delivery-systems/descriptif_3782859
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3782859

Drug Targeting and Stimuli Sensitive Drug Delivery Systems Pharmaceutical Nanotechnology Series

Langue : Anglais

Coordonnateur : Grumezescu Alexandru Mihai

Couverture de l’ouvrage Drug Targeting and Stimuli Sensitive Drug Delivery Systems

Drug Targeting and Stimuli Sensitive Drug Delivery Systems covers recent advances in the area of stimuli sensitive drug delivery systems, providing an up-to-date overview of the physical, chemical, biological and multistimuli-responsive nanosystems. In addition, the book presents an analysis of clinical status for different types of nanoplatforms. Written by an internationally diverse group of researchers, it is an important reference resource for both biomaterials scientists and those working in the pharmaceutical industry who are looking to help create more effective drug delivery systems.

1. Stimuli responsive nanosystems for drug targeted delivery
2. Exploiting the stimuli-sensitive phase behavior of surfactants for delineating drug delivery systems
3. pH responsive “Intelligent” lipid based nanoconstructs for intracellular delivery of bioactives
4. Stimuli sensitive ocular drug delivery systems
5. Stimuli-Responsive Nanomaterials for Antimicrobial Drug Delivery
6. Stimuli-sensitive Delivery Systems
7. A systematic review on the smart polymeric nanocarriers for drug delivery applications
8. Stimuli sensitive systems for camptothecin delivery
9. pH sensitive nanogels: the emerging horizon in drug delivery
10. Design of targeting peptides for nanodrugs for treatment of infectious diseases and cancer
11. Nanoparticles targeting through transdermal in diabetology – an emerging drug carrier system
12. Nanoparticles for drug and gene targeting neurodegeneration in brain and eye
13. Cell and organ drug targeting using nanoparticles
14. Cellular exosomes biogenesis as a recipe for design smart drug delivery systems for cancer therapy
15. Advancements in exogeneous techniques for stimuli sensitive delivery systems
16. Ligand Directed Tumor Targeting with Hybrid Viral Phage Nanoparticles
17. Site specific drug delivery, targeting and Gene therapy
18. Stimuli Responsive Micelles: Nanoplatform for Therapeutic and Diagnostic Applications
Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books.
  • Shows how the use of nanomaterials can help target a drug to specific tissues and cells
  • Explores the development of stimuli-responsive drug delivery systems
  • Includes case studies to showcase how stimuli responsive nanosystems are used in a variety of therapies, including camptothecin delivery, diabetes and cancer therapy

Date de parution :

Ouvrage de 836 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

198,88 €

Ajouter au panier

Thèmes de Drug Targeting and Stimuli Sensitive Drug Delivery Systems :

Mots-clés :

AAVP; Active targeting; Amphiphilic block copolymer; Anti-miR; Antibodies; Antimicrobial; BBB permeability; BBB blood-brain barrier; BKCa calcium-dependent potassium channels; BTB blood-tumor barrier; Biogenesis; Biomaterials; Brain; Cancer; Cancer immunology; Chemical stimuli; Controlled drug release; Controlled release; Corneal permeability; Corneal regeneration; Cross-linking structure; Current applications in cancer therapy; Cyclodextrin; DCE-MRI; Delivery; Delivery systems; Diagnosis; Diagnostic; Drug controlled release; Drug delivery; Drug delivery systems; Drug development; External stimuli; Extracellular vesicles; Gene therapy; Genes; Historical overview; Hybrid phage; Hydrogel; In situ hydrogel; Infectious diseases; Internal stimuli; Interpenetrating polymer network; Isolation and characterization; KATP ATP-sensitive potassium channels; Ligand directed; Lungs; Lymphocytes; MiRNA; Micelles; Modified drug delivery systems; Multimeric molecular imaging; Nanocarriers; Nanodrug delivery; Nanodrugs; Nanomaterials; Nanomedicine; Nanoparticle; Nanoparticles; Nanotechnological vectors; Nanotechnology; Nanotherapeutics; Nanotoxicology; Nanovesicles mimetics; Neutrophils; Nucleic acids; Ocular biodistribution; Ocular drug delivery systems; Ocular residence time; Ocular toxicity; Ophthalmic; Peptides; Physical stimuli; Polymeric nanoparticles; Polymers; Preclinical and clinical status; Quality by design; Receptors; Recombinant; Regulatory affairs; SNEDDs; Site-specific; Skin; Smart material; Smart polymer; Solid lipid nanoparticles; Stimuli sensitive; Stimuli-responsive; Stimuli-responsive nanosystems; Stimuli-sensitive; Stimulus-responsive; Sustained release; Targeted delivery; Targeted therapy; Targeting; Targeting peptides; The role of diagnosis in treatment; Theranostic; Toxicology of nanoparticles; Tumor cells